Assignee
VTV THERAPEUTICS LLC
US·47 granted patents·25 pending applications·174 citations·filing 2013–2025
Top patents by PatentIndex Score
72 records- 0195US10980861B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2020·Granted Apr 20, 2021·4 cites·17 claims
- 0295US10952993B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2020·Granted Mar 23, 2021·5 cites·13 claims
- 0395US10287284B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted May 14, 2019·14 cites·22 claims
- 0494US10947180B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2019·Granted Mar 16, 2021·4 cites·11 claims
- 0593US11130753B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Sep 28, 2021·2 cites·29 claims
- 0693US10456406B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2018·Granted Oct 29, 2019·9 cites·11 claims
- 0793US9968613B2Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2016·Granted May 15, 2018·12 cites·14 claims
- 0893US9487493B2Use of a PPAR-delta agonist for treating muscle atrophyVTV THERAPEUTICS LLC·Filed 2014·Granted Nov 8, 2016·17 cites·20 claims
- 0992US11524942B2Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2021·Granted Dec 13, 2022·2 cites·7 claims
- 1092US9855274B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2017·Granted Jan 2, 2018·7 cites·15 claims
- 1192US9393245B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 1291US10471066B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2017·Granted Nov 12, 2019·6 cites·10 claims
- 1390US11649230B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted May 16, 2023·1 cites·29 claims
- 1490US11096946B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2019·Granted Aug 24, 2021·2 cites·10 claims
- 1590US10889580B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Jan 12, 2021·2 cites·20 claims
- 1690US10064846B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2017·Granted Sep 4, 2018·6 cites·16 claims
- 1790US9855251B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2016·Granted Jan 2, 2018·7 cites·16 claims
- 1889US10363244B2Compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2018·Granted Jul 30, 2019·5 cites·1 claims
- 1988US10004782B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2013·Granted Jun 26, 2018·10 cites·19 claims
- 2088US9663481B2Phenoxy acetic acids and phenyl propionic acids as PPARδ agonistsVTV THERAPEUTICS LLC·Filed 2013·Granted May 30, 2017·7 cites·15 claims
- 2188US9447468B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2013·Granted Sep 20, 2016·5 cites·12 claims
- 2287US10588943B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2018·Granted Mar 17, 2020·5 cites·12 claims
- 2387US9707239B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2016·Granted Jul 18, 2017·3 cites·7 claims
- 2486US11974989B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted May 7, 2024·1 cites·13 claims
- 2586US11833136B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted Dec 5, 2023·1 cites·20 claims
- 2685US10568888B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·16 claims
- 2785US10463652B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2018·Granted Nov 5, 2019·4 cites·7 claims
- 2885US10391097B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2018·Granted Aug 27, 2019·2 cites·16 claims
- 2985US10172840B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2017·Granted Jan 8, 2019·4 cites·6 claims
- 3085US9717710B2Treatment of mild and moderate Alzheimer's diseaseVTV THERAPEUTICS LLC·Filed 2013·Granted Aug 1, 2017·5 cites·22 claims
- 3185US2025288681A1Solid compositions comprising a glucokinase activator and methods of making and using the sameVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3284US10898475B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Jan 26, 2021·2 cites·18 claims
- 3383US10570126B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·21 claims
- 3482US12391658B2Sulfoxide and sulfone glucokinase activators and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted Aug 19, 2025·1 cites·17 claims
- 3581US2024245656A1Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3680US10085990B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Oct 2, 2018·1 cites·16 claims
- 3780US9833457B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Dec 5, 2017·1 cites·19 claims
- 3878US11420929B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2021·Granted Aug 23, 2022·0 cites·5 claims
- 3978US10030011B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 4078US9687489B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2016·Granted Jun 27, 2017·1 cites·11 claims
- 4177US10363241B2Substituted imidazole derivatives and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted Jul 30, 2019·1 cites·3 claims
- 4276US11970457B2Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2022·Granted Apr 30, 2024·0 cites·12 claims
- 4376US11420942B2Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2020·Granted Aug 23, 2022·2 cites·17 claims
- 4476US2022072005A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4576US2025325536A1Therapeutic uses of glp1r agonistsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 4676US2026034107A1Substituted fused imidazole derivatives and methods of treating sickle cell disease and related complicationsVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4774US2026027090A1Methods of Inhibiting Osteoclastogenesis and Osteoclast ActivityVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4874US2022233701A1Solid compositions comprising a glucokinase activator and methods of making and using the sameVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4974US2025360139A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 5069US2021069159A1Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions ThereofVTV THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →